BCM
SSKN

Bridgeway Capital Management’s Strata Skin Sciences SSKN Stock Holding History

Bridgeway Capital Management’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,500
Closed -$301K – 1451
2018
Q3 		$301K Hold
8,500
– – ﹤0.01% 1255
2018
Q2 		$174K Hold
8,500
– – ﹤0.01% 1316
2018
Q1 		$95K Hold
8,500
– – ﹤0.01% 1328
2017
Q4 		$105K Hold
8,500
– – ﹤0.01% 1331
2017
Q3 		$150K Hold
8,500
– – ﹤0.01% 1313
2017
Q2 		$207K Buy
+8,500
New +$237K ﹤0.01% 1285

Other funds holding SSKN

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bridgeway Capital Management's SSKN Position: Q4 2018 in Review

Bridgeway Capital Management sold out of Strata Skin Sciences (SSKN) in Q4 2018, closing a stake of 8,500 shares — an estimated $301K sold.

Bridgeway Capital Management first reported a position in SSKN in Q2 2017 and held it in 6 quarters. The position peaked at $301K in Q3 2018. 25 funds tracked by Wall St. Rank hold SSKN as of Q4 2018.

  • Bridgeway Capital Management reported no remaining Strata Skin Sciences position as of Q4 2018 after selling out during the quarter.
  • Bridgeway Capital Management sold 8,500 Strata Skin Sciences shares in Q4 2018, an estimated $301K.
  • Bridgeway Capital Management first reported a position in Strata Skin Sciences in Q2 2017 and held it in 6 quarters.
  • Bridgeway Capital Management's Strata Skin Sciences position peaked at $301K in Q3 2018.
  • 25 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q4 2018.

Based on Bridgeway Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.